[1]于海波,综述,梁延春,等.经导管主动脉瓣膜置换术后房室传导阻滞的预警[J].心血管病学进展,2016,(4):419-422.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.024]
 YU Haibo,LIANG Yanchun.Predicting Factors of Atrioventricular Block after Transcatheter Aortic Valve Replacement[J].Advances in Cardiovascular Diseases,2016,(4):419-422.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.024]
点击复制

经导管主动脉瓣膜置换术后房室传导阻滞的预警()
分享到:

《心血管病学进展》[ISSN:51-1187/R/CN:1004-3934]

卷:
期数:
2016年4期
页码:
419-422
栏目:
综述
出版日期:
2016-08-15

文章信息/Info

Title:
Predicting Factors of Atrioventricular Block after Transcatheter Aortic Valve Replacement
作者:
于海波综述梁延春审校
沈阳军区总医院心内科,辽宁 沈阳 110016
Author(s):
YU HaiboLIANG Yanchun
Department of Cardiology,The General Hospital of Shenyang Military Region,Shenyang 110016,Liaoning,China
关键词:
主动脉瓣狭窄 经导管主动脉瓣置换术 传导阻滞
Keywords:
Aortic valve stenosis Transcatheter aortic valve replacement Conduction disturbances
分类号:
R654.2
DOI:
10.16806/j.cnki.issn.1004-3934.2016.04.024
文献标志码:
A
摘要:
经导管主动脉瓣置换术是外科手术高危的主动脉瓣狭窄患者的有效替代治疗方式,但术后发生房室传导阻滞并需要植入起搏器的患者比例增高。术后的希氏束与心室之间间期、术后与术前希氏束与心室之间间期之差、术前合并完全性右束支传导阻滞、术后新发的左束支传导阻滞等均为经导管主动脉瓣置换术相关房室传导阻滞的预警因素。
Abstract:
Transcatheter aortic valve replacement(TAVR)is an effective therapy method for aortic stenosis patients intolerable surgical aortic valve replacement. While it is known that the requirement for permanent pacing is higher because of subsequent atrioventricular block. The postprocedural HV interval,a prolonged delta-HV interval,RBBB before TAVR and a new-onset LBBB after TAVR are strongly associated with atrioventricular block.

参考文献/References:

[1] Thomas M, Schymik G, Walther T, et al. Thirty-day results of the SAPIEN aortic Bioprosthesis European Outcome(SOURCE)Registry: a European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve[J]. Circulation,2010,122(1):62-69.
[2] Holmes DR Jr, Mack MJ, Kaul S, et al. 2012 ACCF/AATS/SCAI/STS expert consensus document on transcatheter aortic valve replacement[J]. J Am Coll Cardiol,2012,59(13):1200-1254.
[3] Smith CR, Leon MB, Mack MJ, et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients[J]. N Engl J Med,2011,364(23):2187-2198.
[4] Bagur R, Rodés-Cabau J, Gurvitch R, et al. Need for permanent pacemaker as a complication of transcatheter aortic valve implantation and surgical aortic valve replacement in elderly patients with severe aortic stenosis and similar baseline electrocardiographic findings[J]. JACC Cardiovasc Interv,2012,5(5):540-551.
[5] Smith CR, Leon MB, Mack MJ, et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients[J]. N Engl J Med,2011,36(4):2187-2198.
[6] Zahn R, Gerckens U, Grube E, et al.Transcatheter aortic valve implantation: first results from a multi-centre real-world registry[J]. Eur Heart J,2011,32:198-204.
[7] Thomas M, Schymik G, Walther T, et al. Thirty-day results of the Sapien Aortic Bioprosthesis European outcome(SOURCE)registry: a European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve[J]. Circulation,2010,122:62-69.
[8] Calvi V, Conti S, Pruiti GP, et al. Incidence rate and predictors of permanent pacemaker implantation after transcatheter aortic valve implantation with self-expanding CoreValve prosthesis[J].J Interv Card Electrophysiol, 2012,34(2):189-195.
[9] Akin I, Kische S, Paranskaya L, et al. Predictive factors for pacemaker requirement after transcatheter aortic valve implantation[J]. BMC Cardiovasc Disord,2012,12:87.
[10] Akin I, Kische S, Schneider H, et al. Surface and intracardiac ECG for discriminating conduction disorders after CoreValve implantation[J]. Clin Res Cardiol,2012,101:357-364.
[11] Eksik A, Gul M, Uyarel H, et al. Electrophysiological evaluation of atrioventricular conduction disturbances in transcatheter aortic valve implantation with Edwards SAPIEN prosthesis[J]. J Invasive Cardiol,2013,25(6):305-309.
[12] Rivard L, Schram G, Asgar A, et al. Electrocardiographic and electrophysiological predictors of atrioventricular block after transcatheter aortic valve replacement[J]. Heart Rhythm,2015,12(2):321-329.
[13] Bleiziffer S, Ruge H, Horer J,et al. Predictors for new-onset complete heart block after transcatheter aortic valve implantation[J]. JACC Cardiovasc Interv,2010,3: 524-530.
[14] Jilaihawi H, Chin D, Vasa-Nicotera M, et al. Predictors for permanent pacemaker requirement after transcatheter aortic valve implantation with the CoreValve bioprosthesis[J]. Am Heart J,2009,157:860-866.
[15] Baan J Jr, Yong ZY, Koch KT, et al. Factors associated with cardiac conduction disorders and permanent pacemaker implantation after percutaneous aortic valve implantation with the CoreValve prosthesis[J]. Am Heart J,2010,159:497-503.
[16] Piazza N, Onuma Y, Jesserun E, et al. Early and persistent intraventricular conduction abnormalities and requirements for pacemaking after percutaneous replacement of the aortic valve[J]. JACC Cardiovasc Interv,2008,1:310-316.
[17] Fraccaro C, Buja G, Tarantini G, et al. Incidence, predictors, and outcome of conduction disorders after transcatheter self-expandable aortic valve implantation[J]. Am J Cardiol,2011,107:747-754.
[18] Urena M, Mok M, Serra V, et al. Predictive factors and long-term clinical consequences of persistent left bundle branch block following transcatheter aortic valve implantation with a balloon-expandable valve[J]. J Am Coll Cardiol,2012,60: 1743-1752.
[19] Dawkins S, Hobson AR, Kalra PR, et al. Permanent pacemaker implantation after isolated aortic valve replacemen incidence, indications, and predictors[J]. Ann Thorac Surg,2008,85:108-112.
[20] Limongelli G, Ducceschi V, D'Andrea A, et al. Risk factors for pacemaker implantation following aortic valve replacement: a single centre experience[J]. Heart,2003,89:901-904.
[21] Houthuizen P, van Garsse LA, Poels TT, et al. Left bundle-branch block induced by transcatheter aortic valve implantation increases risk of death[J].Circulation,2012,126:720-728.

相似文献/References:

[1]谢晓川,饶莉.经导管主动脉瓣植入术临床研究进展[J].心血管病学进展,2015,(6):700.[doi:10.3969/j.issn.1004-3934.2015.06.011]
 XIE Xiaochuan,RAO Li.Clinical Research Progress in Transcatheter Aortic Valve Implantation[J].Advances in Cardiovascular Diseases,2015,(4):700.[doi:10.3969/j.issn.1004-3934.2015.06.011]
[2]于子凯 许海燕 刘庆荣 吴永健.合并常见疾病对经导管主动脉瓣置换术患者预后的影响[J].心血管病学进展,2019,(5):697.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.009]
 YU Zikai,XU Haiyan,LIU Qingrong,et al.Influence of ommon Accompanied Diseases on Prognosis of Patients after Transcatheter Aortic Valve Replacement[J].Advances in Cardiovascular Diseases,2019,(4):697.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.009]
[3]邵美华 周玉强 王萌萌 王宝珠 马翔.经导管主动脉瓣置换术治疗二叶式主动脉瓣狭窄研究进展[J].心血管病学进展,2020,(11):1184.[doi:10.16806/j.cnki.issn.1004-3934.2020.11.000]
[4]夏平.“8+2”心电图临床价值的研究进展夏平[J].心血管病学进展,2021,(9):800.[doi:【DOI】10.16806/j.cnki.issn.1004-3934.2021.09.009]
 XIA Ping.Clinical Value of 8 Plus 2 ECG[J].Advances in Cardiovascular Diseases,2021,(4):800.[doi:【DOI】10.16806/j.cnki.issn.1004-3934.2021.09.009]
[5]李宗泽 何贵均 郑晓菲 蒋晖 刘汉雄.经导管主动脉瓣置换术后合并心房颤动的抗栓策略[J].心血管病学进展,2021,(10):892.[doi:10.16806/j.cnki.issn.1004-3934.2021.10.007]
 LI ZongzeHE GuijunZHENG XiaofeiJIANG HuiLIU Hanxiong.Optimal Antithrombotic Strategies after Transcatheter Aortic Valve Replacement in Patients with Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2021,(4):892.[doi:10.16806/j.cnki.issn.1004-3934.2021.10.007]
[6]王卫卫 于子凯 吴永健 许海燕 刘庆荣.序贯综合心脏康复模式在经导管主动脉瓣置换术患者中应用现状[J].心血管病学进展,2022,(8):673.[doi:10.16806/j.cnki.issn.1004-3934.2022.08.001]
 WANG Weiwei,YU Zikai,WU YongjianXU HaiyanLIU Qingrong.The Status of Sequential Comprehensive Cardiac Rehabilitation in Patients?ndergoing Transcatheter Aortic Valve Replacement[J].Advances in Cardiovascular Diseases,2022,(4):673.[doi:10.16806/j.cnki.issn.1004-3934.2022.08.001]
[7]张航 安景辉 石凤梧.极简式经导管主动脉瓣置换术的研究现状[J].心血管病学进展,2022,(9):812.[doi:10.16806/j.cnki.issn.1004-3934.2022.09.011]
 ZHANG Hang,AN Jinghui,SHI Fengwu.Minimalist Transcatheter Aortic Valve Replacement[J].Advances in Cardiovascular Diseases,2022,(4):812.[doi:10.16806/j.cnki.issn.1004-3934.2022.09.011]
[8]达尼亚尔·迪力木拉提 施林 严飞.二叶式主动脉瓣发病机制及其临床诊治的研究进展[J].心血管病学进展,2023,(5):412.[doi:10.16806/j.cnki.issn.1004-3934.2023.05.007]
 Daniyar·Dilmurat,SHI Lin,YAN Fei.The PathogenesisClinical Diagnosis and Treatment of Bicuspid Aortic Valve[J].Advances in Cardiovascular Diseases,2023,(4):412.[doi:10.16806/j.cnki.issn.1004-3934.2023.05.007]

备注/Memo

备注/Memo:
作者简介:于海波(1974—),副主任医师,博士,主要从事心脏起搏与心电生理研究。Email:yuhaibo-74@126.com 通信作者:梁延春(1966—),主任医师,博士,主要从事心脏起搏与心电生理研究。Email:liangyanchun@sina.com
更新日期/Last Update: 2016-07-25